Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review
Edoardo Caronna(Universitat Autònoma de Barcelona), Patricia Pozo‐Rosich(Vall d'Hebron Institut de Recerca), Hayrünnisa Bolay(Gazi University), Massimiliano Valeriani(University of Rome Tor Vergata), David García‐Azorín(Universidad de Valladolid), Messoud Ashina(University of Copenhagen), Karl Meßlinger(Friedrich-Alexander-Universität Erlangen-Nürnberg), Hans‐Christoph Diener(University of Birmingham), Thomas C. van den Hoek(Leiden University Medical Center), Cristina Tassorelli(University of Pavia), Gisela M. Terwindt(Leiden University Medical Center), Ana Beatriz Gago‐Veiga(Hospital Universitario de La Princesa), Tsubasa Takizawa(Keio University), Robert E. Shapiro(University of Vermont), Peter J. Goadsby(King's College London)
Cited by 55
Related Papers
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Migraine
|New England Journal of Medicine|2020|819
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|809
Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine
|Nature Genetics|2016|701